Sulfonylureas stimulate renin secretion from the perfused kidney of the rat

Nephron

Volumn 81, Issue 1, 1999, Pages 67-71

  Ochi, Hiroshi ^a   Ikeda, Tadasu ^b  

^a Hakuai Hospital   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Calcium; cAMP; Chlorpropamide; Glibenclamide; Perfused kidney; Rat; Renin secretion; Tolbutamide

Indexed keywords

CALCIUM; CHLORPROPAMIDE; CYCLIC AMP; GLIBENCLAMIDE; RENIN; SULFONYLUREA; TOLBUTAMIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ISOLATED KIDNEY; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENIN RELEASE;

ANIMALS; BLOOD PRESSURE; CHLORPROPAMIDE; CYCLIC AMP; GLYBURIDE; HYPOGLYCEMIC AGENTS; KIDNEY; MALE; PERFUSION; RATS; RATS, WISTAR; RENIN; STIMULATION, CHEMICAL; SULFONYLUREA COMPOUNDS; TOLBUTAMIDE;

EID: 0032918495     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045248     Document Type: Article

References (26)

1. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of angiotensin I-converting enzyme gene. Diabetes 1994;43:690-695.
2. Drury PL, Bodansky HJ: The relationship of the renin-angiotensin system in type I diabetes to microvascular disease. Hypertension 1985; 7(suppl II):84-89.
3. Ravid M, Savin H, Jutrin I: Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-581.
4. Schmidt S, Schone N, Ritz E: The Diabetic Nephropathy Study Group, Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995;47:1176-1181.
5. Churchill PC, McDonald FD, Churchill MC: Effect of diltiazem, a calcium antagonist, on renin secretion from rat kidney slices. Life Sci 1981;29:383-389.
6. Churchill MC, Churchill PC, McDonald FD: Comparison of the effects of rubidium and potassium on renin secretion from rat kidney slices. Endocrinology 1983;112:777-781.
7. Matsumura Y, Sasaki Y, Shinyama H, Morimoto S: The calcium channel agonist. Bay K 8644, inhibits renin release from rat kidney cortical slices. Eur J Pharmacol 1985;117:369-372.
8. Boyd AE: Sulphonylurea receptors, ion channels and fruit flies. Diabetes 1988;37:847-850.
9. Christlieb AR: Diabetes and hypertensive vascular disease. Am J Cardiol 1973;32:592-606.
10. Sherma NK, Gossain VV, Michelakis AM, Rovner DR: Effect of tolbutamide on plasma renin activity. Am J Physiol 1979;236:E1-3.
11. Linseman DA, Lawson JA, Jones DA, Ludens JH: Glyburide attenuates calmodulin antagonist-stimulated renin release from isolated mouse juxtaglomerular cells. Am J Physiol 1995;269:F242-F247.
12. Gutman Y, Benzakein F: Effect of phenformin and chlorpropamide on renin activity in the rat. Experientia 1971;27:1313-1314.
13. Welch WJ, Ott CE, Lorenz JN, Kotchen TA: Effects of chlorpropamide on loop of Henle function and plasma renin. Kid Int 1986;30: 712-716.
14. Ikeda T, Ito Y, Murakami I, Mokuda O, Kuno S, Tokumori Y, Tominaga M, Mashiba H: Effect of diabetes on triiodothyronine and reverse triiodothyronine production in the perfused rat liver and kidney. Diabetes 1985;34: 647-652.
15. Nishiitsutsuji-Uwo JM, Ross BD, Krebs HA: Metabolic activities of the isolated perfused kidney. Biochem J 1967;103:852-862.
16. Melander A, Sartor G, Wåhlin E, Scherstén B, Bitzén P-O: Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. Br Med J 1978;21:142-144.
17. Sartor G, Melander A, Scherstén B, Wåhlin-Boll E: Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 1980;18: 17-22.
18. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci 1990;47:1693-1705.
19. Ferrier CP, Kurtz A, Lehner P, Shaw SG, Pusterla C, Saxenhofer H, Weidmann P: Stimulation of renin secretion by potassium-channel activation with cromakalim. Eur J Clin Pharmacol 1989;36:443-447.
20. + channel activators, RP52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. J Pharmacol Exp Ther 1991;258:216-222.
21. + channel. J Biol Chem 1996; 271:24321-24324.
22. Michelakis AM, Caudle J, Liddle GW: In vitro stimulation of renin production by epinephrine, norepinephrine and cyclic AMP. Proc Soc Exp Biol Med 1969;130:748-753.
23. Winer N, Chokshi DS, Walkenhorst WG: Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion. Circ Res 1971;29:239-248.
24. Peart WS, Quesada T, Tengi I: The effects of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate and theophylline on renin secretion in the isolated perfused kidney of the rat. Br J Pharmacol 1975;54:55-60.
25. Viskoper RJ, Maxwell MH, Lupu AN, Rosenfield S: Renin stimulation by isoproterenol and theophylline in the isolated perfused kidney. Am J Physiol 1977;232:F248-253.
26. Brooker G, Fichman M: Chlorpropamide and tolbutamide inhibition of adenosine 3′5′-cyclic monophosphate phosphodiesterase. Biochem Biophys Res Commun 1971;42:824-828.